Violet Therapeutics: Valuation, Funding & Investors
Violet Therapeutics is a preclinical-stage biotechnology company developing first-in-class therapies for neurodegenerative disease by mapping disease-relevant cell-to-cell signaling interactions in the brain. The company’s proprietary CONNECT platform is designed to identify therapeutically actionable signaling pathways that drive neuroinflammation, neurodegeneration, and synaptic loss.
Leadership & Board
- Current Number of Employees
- 13
- Current LinkedIn Followers
- 991
Latest Estimated Valuation
- Total Amount Raised
- $5M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $5M
- Latest Funding Round
- Seed Round
Employee Trend
Violet Therapeutics had 13 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Violet Therapeutics had 991 followers as of November 16, 2026. The number of followers increased by 4 (0.41%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| May 18, 2026 | Seed Round | $4.75M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| LifeSpan Vision Ventures | Seed Round |
| Dementia Discovery Fund | Seed Round |
| UTEC | Seed Round |
| Ono Venture Investment | Seed Round |
| Mass General Brigham Ventures | Seed Round |
Similar Companies
A snapshot of private companies similar to Violet Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis







